KMTSKestra Medical Technologies, Ltd.
Is the business good?
5 of 9 health tests passed. That is the only one of 4 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Mixed fundamental signals. Nine pass/fail tests of year-over-year health from the filings.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is KMTS?
Kestra Medical Technologies, Ltd. keeps −134% of every revenue dollar as operating profit, against 6.6% for the median Medical Instruments & Supplies name.
Operating margin · Medical Instruments & Supplies median 6.6% · 12 months to Q1 2027
- Share count, year on year
- +14%
Share count, year on year · shareholders own a smaller slice than a year ago
- R&D as % of revenue
- 21%
R&D as % of revenue
- Gross margin
- 54%
Gross margin
| Year | Operating margin |
|---|---|
| FY2024 | −306% |
| FY2025 | −178% |
| FY2026 | −142% |
Details›
- Gross margin12 months to Q1 2027
- 54%
- Operating margin12 months to Q1 2027
- −134%
- Net margin12 months to Q1 2027
- −140%
- Free cash flow margin
- −115%
- R&D as % of revenue
- 21%
- Revenue, trailing twelve months
- $107M
- Free cash flow, trailing twelve months
- −$123M
- Net income, trailing twelve months
- −$150M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Medical Instruments & Supplies
The closest names by size in the same industry